Related Experiment Video
Updated: Feb 14, 2026

10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
14.0K
Chronic Right Ventricular Pacing in the Heart Failure Population
Justin Gould1,2, Benjamin Sieniewicz3,4, Bradley Porter3,4
1King's College London, London, UK. justin.s.gould@kcl.ac.uk.
Current Heart Failure Reports
|February 14, 2018
Summary
Right ventricular apical pacing may harm patients with heart failure and AV block. Cardiac resynchronization therapy (CRT) shows benefits for some, but its effectiveness in mild heart failure requires further study.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Right ventricular (RV) apical pacing is a common treatment for atrioventricular (AV) block.
- Concerns exist regarding potentially harmful effects of RV apical pacing.
- Cardiac resynchronization therapy (CRT) is an alternative for heart failure patients.
Purpose of the Study:
- To review trials on harmful effects of RV apical pacing.
- To evaluate alternative RV pacing sites.
- To assess CRT's role in heart failure with AV block.
Main Methods:
- Review of clinical trials and existing evidence.
- Analysis of outcomes comparing CRT and RV pacing.
- Focus on patients with heart failure and AV block.
Main Results:
- CRT may improve left ventricular function and reverse remodeling in moderate-to-severe heart failure with AV block compared to RV pacing.
- The BLOCK HF trial showed better outcomes with CRT but no mortality benefit in specific patient groups.
- CRT benefits in mild left ventricular dysfunction with AV block are less clear.
Conclusions:
- CRT is a viable option for select heart failure patients with AV block and impaired left ventricular function.
- RV apical pacing may have detrimental effects.
- Further research is needed to clarify CRT's role in milder forms of left ventricular dysfunction.
Related Concept Videos
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
966
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies
402
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management
369
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369

